Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV000650484 | SCV000772330 | uncertain significance | Hyperphosphatasia with intellectual disability syndrome 2 | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with methionine at codon 958 of the PIGO protein (p.Leu958Met). The leucine residue is moderately conserved and there is a small physicochemical difference between leucine and methionine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with PIGO-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Ambry Genetics | RCV004649246 | SCV005153603 | uncertain significance | Inborn genetic diseases | 2024-05-23 | criteria provided, single submitter | clinical testing | The c.2872C>A (p.L958M) alteration is located in exon 9 (coding exon 8) of the PIGO gene. This alteration results from a C to A substitution at nucleotide position 2872, causing the leucine (L) at amino acid position 958 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |